ctrl K

Price Alert

Iovance Biotherapeutics I... (IOVA)

NASDAQ: IOVA · Real-Time Price · USD

2.54

0.09 (3.67%)

At close: Aug 15, 2025, 3:59 PM

2.57

0.98%

After-hours: Aug 15, 2025, 04:16 PM EDT

Iovance Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	115.69M	114.89M	231.73M	78.23M
Short-Term Investments	208.09M	164.98M	240.11M	426.18M
Long-Term Investments	n/a	66.43M	6.43M	91.59M
Other Long-Term Assets	6.73M	270K	-178.25M	7.87M
Receivables	69.34M	151K	n/a	n/a
Inventory	51.52M	10.37M	n/a	n/a
Other Current Assets	12.38M	17.46M	7.27M	n/a
Total Current Assets	457.02M	307.85M	479.12M	507.96M
Property-Plant & Equipment	164.28M	176.54M	178.25M	169.92M
Goodwill & Intangibles	282.4M	229.26M	n/a	n/a
Total Long-Term Assets	453.41M	472.5M	6.43M	269.38M
Total Assets	910.43M	780.35M	663.98M	777.33M
Account Payables	27.51M	33.12M	26.6M	27.38M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	12.9M	7.78M	12.59M	5.06M
Other Current Liabilities	69.04M	26.82M	20.3M	30.2M
Total Current Liabilities	122.34M	110.31M	91.48M	89.2M
Long-Term Debt	1M	1M	1M	1M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	77.68M	85.43M	72.86M	66.47M
Total Liabilities	200.02M	195.74M	164.34M	155.67M
Total Debt	58.26M	75.86M	85.45M	71.53M
Common Stock	13K	11K	8K	7K
Retained Earnings	-2.38B	-2.01B	-1.57B	-1.17B
Comprehensive Income	-1.05M	2.53M	-902K	-601K
Shareholders Equity	710.4M	584.61M	499.64M	621.66M
Total Investments	208.09M	164.98M	240.11M	517.77M